Michael P. Pollastri

2.7k total citations
69 papers, 1.8k citations indexed

About

Michael P. Pollastri is a scholar working on Epidemiology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael P. Pollastri has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 32 papers in Organic Chemistry and 30 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael P. Pollastri's work include Trypanosoma species research and implications (42 papers), Research on Leishmaniasis Studies (27 papers) and Synthesis and Biological Evaluation (20 papers). Michael P. Pollastri is often cited by papers focused on Trypanosoma species research and implications (42 papers), Research on Leishmaniasis Studies (27 papers) and Synthesis and Biological Evaluation (20 papers). Michael P. Pollastri collaborates with scholars based in United States, Spain and Switzerland. Michael P. Pollastri's co-authors include R. Keith Campbell, Kojo Mensa‐Wilmot, Emanuele Amata, Ana Rodrı́guez, Michael H. Gelb, Nicholas D. Bland, Gautam Patel, Jessey Erath, Stefan O. Ochiana and Richard J. Sciotti and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Michael P. Pollastri

67 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Pollastri United States	26	666	653	651	587	207	69	1.8k
Mohammad Imran Siddiqi India	33	1.3k 2.0×	1.0k 1.6×	448 0.7×	655 1.1×	540 2.6×	186	3.1k
Yew Mun Lee Singapore	20	825 1.2×	237 0.4×	235 0.4×	362 0.6×	211 1.0×	33	1.7k
Ivan da Rocha Pitta Brazil	28	891 1.3×	823 1.3×	182 0.3×	208 0.4×	105 0.5×	176	2.6k
Robert T. Jacobs United States	27	755 1.1×	625 1.0×	515 0.8×	413 0.7×	100 0.5×	43	1.9k
Roberta Ettari Italy	27	991 1.5×	742 1.1×	447 0.7×	494 0.8×	204 1.0×	93	2.1k
Sandra Duffy Australia	30	931 1.4×	867 1.3×	228 0.4×	726 1.2×	222 1.1×	92	2.8k
Larry W. Hardy United States	19	1.2k 1.8×	316 0.5×	425 0.7×	446 0.8×	53 0.3×	36	1.7k
Eva S. Istvan United States	17	1.3k 1.9×	169 0.3×	260 0.4×	665 1.1×	558 2.7×	24	2.9k
Sandra Gemma Italy	35	1.4k 2.2×	1.3k 2.0×	257 0.4×	347 0.6×	656 3.2×	132	3.4k
S.K. Puri India	31	720 1.1×	1.5k 2.3×	180 0.3×	878 1.5×	276 1.3×	95	2.9k

Countries citing papers authored by Michael P. Pollastri

Since Specialization

Citations

This map shows the geographic impact of Michael P. Pollastri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Pollastri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Pollastri more than expected).

Fields of papers citing papers by Michael P. Pollastri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Pollastri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Pollastri. The network helps show where Michael P. Pollastri may publish in the future.

Co-authorship network of co-authors of Michael P. Pollastri

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Pollastri. A scholar is included among the top collaborators of Michael P. Pollastri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Pollastri. Michael P. Pollastri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrins, Lori, Rosario Díaz-González, Carlos Cordón-Obras, et al.. (2024). Pharmacophore Identification and Structure–Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of Trypanosoma brucei. Journal of Medicinal Chemistry. 67(16). 13985–14006.

Dichiara, Maria, Hitesh B. Jalani, Edwin G. Tse, et al.. (2023). Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis. ACS Infectious Diseases. 9(8). 1470–1487. 1 indexed citations

Chai, Jing, et al.. (2023). Synthesis of a DNA-Encoded Macrocyclic Library Utilizing Intramolecular Benzimidazole Formation. Bioconjugate Chemistry. 34(6). 988–993. 10 indexed citations

Fayyad, Usama M., et al.. (2023). Understanding and Fostering Regional Artificial Intelligence Ecosystems: A Case Study in Maine. SHILAP Revista de lepidopterología. 5(4).

Singh, Baljinder, Amrita Sharma, Gunaganti Naresh, et al.. (2023). Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery. Journal of Medicinal Chemistry. 66(3). 1972–1989. 6 indexed citations

Chai, Jing, Xiaojie Lu, Christopher C. Arico-Muendel, Yun Ding, & Michael P. Pollastri. (2021). Application of l-Threonine Aldolase to on-DNA Reactions. Bioconjugate Chemistry. 32(9). 1973–1978. 9 indexed citations

Díaz-González, Rosario, Guiomar Pérez‐Moreno, Raquel García‐Hernández, et al.. (2019). Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents. PLoS neglected tropical diseases. 13(2). e0007129–e0007129. 3 indexed citations

Ferrins, Lori, Amrita Sharma, Jessey Erath, et al.. (2018). Anilinoquinoline based inhibitors of trypanosomatid proliferation. PLoS neglected tropical diseases. 12(11). e0006834–e0006834. 8 indexed citations

Kunz, Stefan, Vreni Balmer, Geert Jan Sterk, et al.. (2017). The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target. PLoS neglected tropical diseases. 11(9). e0005891–e0005891. 17 indexed citations

10.

Gelb, Michael H., et al.. (2016). Repurposing strategies for tropical disease drug discovery. Bioorganic & Medicinal Chemistry Letters. 26(11). 2569–2576. 82 indexed citations

11.

Purmal, Andrei A., et al.. (2016). Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis. Scientific Reports. 6(1). 32083–32083. 25 indexed citations

12.

Kozakov, Dima, David R. Hall, Stefan Jehle, et al.. (2015). Ligand deconstruction: Why some fragment binding positions are conserved and others are not. Proceedings of the National Academy of Sciences. 112(20). E2585–94. 56 indexed citations

13.

Shivanna, Sowmya, Kumaran Kolandaivelu, Moshe Shashar, et al.. (2015). The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia. Journal of the American Society of Nephrology. 27(1). 189–201. 87 indexed citations

14.

Pollastri, Michael P.. (2014). Finding New Collaboration Models for Enabling Neglected Tropical Disease Drug Discovery. PLoS neglected tropical diseases. 8(7). e2866–e2866. 9 indexed citations

15.

Lowe, Margaret M., Jeff E. Mold, Bittoo Kanwar, et al.. (2014). Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production. PLoS ONE. 9(2). e87877–e87877. 106 indexed citations

16.

Amata, Emanuele, Nicholas D. Bland, Charles Tapley Hoyt, et al.. (2014). Repurposing human PDE4 inhibitors for neglected tropical diseases: Design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(17). 4084–4089. 22 indexed citations

17.

Woodring, Jennifer L., Nicholas D. Bland, Stefan O. Ochiana, R. Keith Campbell, & Michael P. Pollastri. (2013). Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1). Bioorganic & Medicinal Chemistry Letters. 23(21). 5971–5974. 8 indexed citations

18.

Wang, Cuihua, Trent D. Ashton, Nicholas D. Bland, et al.. (2012). Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 1. Sildenafil analogs. Bioorganic & Medicinal Chemistry Letters. 22(7). 2579–2581. 18 indexed citations

19.

Anderson, Amy C., Michael P. Pollastri, Celia A. Schiffer, & Norton P. Peet. (2011). The challenge of developing robust drugs to overcome resistance. Drug Discovery Today. 16(17-18). 755–761. 18 indexed citations

20.

Pollastri, Michael P., et al.. (2009). Identification and Characterization of Kava‐derived Compounds Mediating TNF‐α Suppression. Chemical Biology & Drug Design. 74(2). 121–128. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact